drugset / Trial / NCT02360358
Autologous Skin Substitute for Chronic Leg/Foot Ulcers.
Phase 1/2
Terminated
8 enrolled
Chantal Blok
ZonMw: The Netherlands Organisation for Health Research and Development · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
A prospective, multicenter, randomised controlled phase II study in which patients with therapy resistant (arterio-) venous leg/foot ulcers are treated with Tiscover® (test group) or with AS210 (control group) to determine the safety and relative efficacy of both products.
Timeline
- Start
- 2012-08
- Primary completion
- 2015-12
- Completion
- 2015-12
Outcome
Outcome not reported
Stopped: “slow inclusion”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tiscover | Cell therapy | — | Topical |